Ocugen (OCGN) Change in Account Payables (2014 - 2019)
Ocugen (OCGN) posted Change in Account Payables of -$560000.0 for Q2 2019, down 14.05% on a QoQ basis from -$491000.0 in Q1 2019, and down 166.27% year-over-year from $845000.0 in Q2 2018.
Ocugen (OCGN) Change in Account Payables (2014 - 2019) Analysis & Trends
Ocugen's Change in Account Payables history runs 6 years deep, the most recent figure standing at -$560000.0 for Q2 2019.
- Quarterly Change in Account Payables fell 166.27% year-over-year to -$560000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$2.9 million (down 617.57% YoY) and the FY2018 annual result came in at -$375000.0, up 55.83% from the prior year.
- Change in Account Payables was -$560000.0 for Q2 2019 at Ocugen, down from -$491000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.2 million in Q3 2015 and bottomed at -$1.8 million in Q1 2015.
- A 5-year average of -$33611.1 and a median of -$225500.0 in 2016 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 1033.82% in 2015, while the deepest fall reached 5450.0% in 2015.
- Ocugen's Change in Account Payables stood at -$772000.0 in 2015, then surged by 129.15% to $225000.0 in 2016, then tumbled by 139.11% to -$88000.0 in 2017, then sank by 1304.55% to -$1.2 million in 2018, then soared by 54.69% to -$560000.0 in 2019.
- Business Quant data shows OCGN's Change in Account Payables at -$560000.0 in Q2 2019, -$491000.0 in Q1 2019, and -$1.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -560,000.00 |
| Jun 30, 2019 | -560,000.00 |
| Mar 31, 2019 | -491,000.00 |
| Mar 31, 2019 | -491,000.00 |
| Dec 31, 2018 | -1.24 Mn |
| Dec 31, 2018 | -1.24 Mn |
| Sep 30, 2018 | -570,000.00 |
| Sep 30, 2018 | -570,000.00 |
| Jun 30, 2018 | 845,000.00 |
| Jun 30, 2018 | 845,000.00 |
| Mar 31, 2018 | 586,000.00 |
| Mar 31, 2018 | 586,000.00 |
| Dec 31, 2017 | -88,000.00 |
| Dec 31, 2017 | -88,000.00 |
| Sep 30, 2017 | -791,000.00 |
| Sep 30, 2017 | -791,000.00 |
| Jun 30, 2017 | 390,000.00 |
| Jun 30, 2017 | 390,000.00 |
| Mar 31, 2017 | -360,000.00 |
| Mar 31, 2017 | -360,000.00 |